EMBECTA CORP. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
EMBECTA CORP. (EMBC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $4.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $4.20M, a 28.81% decline year-over-year.
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $5.70M, a 21.92% decline year-over-year.
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $5.90M, a 33.71% decline year-over-year.
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $9.50M, a 53.23% increase year-over-year.
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $31.60M, a 20.15% increase from fiscal 2024.
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $26.30M, a 22.33% increase from fiscal 2023.
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $21.50M, a 115.00% increase from fiscal 2022.
- EMBECTA CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $10.00M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $4.20M 10-Q · filed 2026-08-07 | $9.90M derived: sum of 2 quarters · filed 2026-08-07 | $15.80M 10-Q · filed 2026-08-07 | $25.30M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $5.70M 10-Q · filed 2026-05-05 | $11.60M 10-Q · filed 2026-05-05 | $21.10M derived: sum of 3 quarters · filed 2026-05-05 | $27.00M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $5.90M 10-Q · filed 2026-02-05 | $15.40M derived: sum of 2 quarters · filed 2026-02-05 | $21.30M derived: sum of 3 quarters · filed 2026-08-07 | $28.60M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-09-30 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $15.40M derived: sum of 2 quarters · filed 2026-08-07 | $22.70M derived: sum of 3 quarters · filed 2026-08-07 | $31.60M 10-K · filed 2025-11-25 | |
| 2025-06-30 | $5.90M 10-Q · filed 2026-08-07 | $13.20M derived: sum of 2 quarters · filed 2026-08-07 | $22.10M 10-Q · filed 2026-08-07 | $28.30M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $7.30M 10-Q · filed 2026-05-05 | $16.20M 10-Q · filed 2026-05-05 | $22.40M derived: sum of 3 quarters · filed 2026-05-05 | $28.90M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $8.90M 10-Q · filed 2026-02-05 | $15.10M derived: sum of 2 quarters · filed 2026-02-05 | $21.60M derived: sum of 3 quarters · filed 2026-02-05 | $28.10M derived: sum of 4 quarters · filed 2026-02-05 | |
| 2024-09-30 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $12.70M derived: sum of 2 quarters · filed 2025-11-25 | $19.20M derived: sum of 3 quarters · filed 2025-11-25 | $26.30M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $6.50M 10-Q · filed 2025-08-08 | $6.30M 10-Q · filed 2024-08-09 | $13.00M derived: sum of 2 quarters · filed 2025-08-08 | $20.10M 10-Q · filed 2025-08-08 | $25.20M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $6.50M 10-Q · filed 2025-05-09 | $13.80M 10-Q · filed 2025-05-09 | $18.70M derived: sum of 3 quarters · filed 2025-11-25 | $24.20M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2023-12-31 | $7.30M 10-Q · filed 2025-02-06 | $12.20M derived: sum of 2 quarters · filed 2025-11-25 | $17.70M derived: sum of 3 quarters · filed 2025-11-25 | $23.30M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2023-09-30 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $10.40M derived: sum of 2 quarters · filed 2025-11-25 | $16.00M derived: sum of 3 quarters · filed 2025-11-25 | $21.50M 10-K · filed 2025-11-25 | |
| 2023-06-30 | $5.50M 10-Q · filed 2024-08-09 | $11.10M derived: sum of 2 quarters · filed 2024-08-09 | $16.60M 10-Q · filed 2024-08-09 | $20.80M derived: sum of 4 quarters · filed 2024-12-11 | |
| 2023-03-31 | $5.60M 10-Q · filed 2024-05-09 | $11.10M 10-Q · filed 2024-05-09 | $15.30M derived: sum of 3 quarters · filed 2024-12-11 | $21.10M derived: sum of 4 quarters · filed 2024-12-11 | |
| 2022-12-31 | $5.50M 10-Q · filed 2024-02-09 | $9.70M derived: sum of 2 quarters · filed 2024-12-11 | $15.50M derived: sum of 3 quarters · filed 2024-12-11 | ||
| 2022-09-30 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $10.00M derived: sum of 2 quarters · filed 2024-12-11 | $10.00M 10-K · filed 2024-12-11 | ||
| 2022-06-30 | $5.80M 10-Q · filed 2023-08-08 | $5.80M 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |